Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 24, 2023
Patent Application Number
17195226
Date Filed
March 8, 2021
Patent Citations
Patent Primary Examiner
The present invention relates to antibodies and antigen-binding fragments thereof that bind to PD-1, and to methods of using such antibodies and antigen-binding fragments. For example, the present invention provides humanized anti-PD-1 antibodies and methods of use thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
